Ideos (Colecalciferol, Calcium Carbonate)

Colecalciferol is vitamin D3, which after absorption is hydroxylated in the liver to 25‑hydroxyvitamin D and then in the kidney to the active hormone 1,25‑dihydroxyvitamin D. This active form binds to the vitamin D receptor in intestinal cells, stimulating the production of calcium‑binding proteins and increasing calcium absorption from the gut, thereby supporting bone mineralization.

The appropriate dose of Ideos is determined by a qualified healthcare professional based on the individual’s age, laboratory results, and clinical condition. Prescribers consider factors such as baseline vitamin D status, calcium intake, and any concurrent medications before recommending a specific dosage regimen.

Safety data for colecalciferol and calcium carbonate in pregnancy and lactation are limited, and the product should only be used if the prescriber judges that the potential benefit outweighs any possible risk. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their healthcare provider.

To place an order, submit an enquiry on the Ideos product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ideos combines colecalciferol and calcium carbonate in a single oral formulation, offering the convenience of a combined supplement. Compared with separate vitamin D or calcium tablets, Ideos reduces pill burden and ensures coordinated dosing, while providing comparable bioavailability of both nutrients when taken with food.

Ideos should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed and out of reach of children. Do not use the product after the expiry date printed on the label.

Ideos is taken orally, usually with a meal to enhance calcium absorption. The tablet should be swallowed whole with a glass of water; it should not be crushed, chewed, or dissolved unless specifically instructed by a healthcare professional.

The most serious risks involve excessive calcium levels, such as hypercalcemia or hypercalciuria, which can lead to kidney stones, cardiac arrhythmias, or renal impairment. Patients should be monitored for symptoms like persistent nausea, vomiting, confusion, or increased thirst, and serum calcium should be checked regularly if high‑dose therapy is used.

Ideos should be avoided in individuals with known hypersensitivity to colecalciferol, calcium carbonate, or any excipients in the tablet. It is also contraindicated in patients with severe hypercalcemia, hypervitaminosis D, or those receiving high‑dose vitamin D or calcium therapy without medical supervision.